HTA49 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in El Salvador
In El Salvador, the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) are available to prevent invasive pneumococcal disease (IPD) such as meningitis, bacteremia, as well as community-acquired pneumococcal pneumonia (CAP) caused by serotypes contained in these vaccines. This analysis estimated the clinical and economic values of PCV13 and PPSV23 from the public healthcare perspective.
Source: Value in Health - Category: International Medicine & Public Health Authors: J. Ordo ñez, J.J. Baldi Castro Source Type: research
More News: El Salvador Health | International Medicine & Public Health | Men | Meningitis | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Vaccines